论文部分内容阅读
目的观察艾迪注射液联合顺铂与氟尿嘧啶治疗晚期食管癌的效果。方法将晚期食管癌患者42例随机分为观察组与对照组各21例。对照组给予顺铂联合氟尿嘧啶治疗,观察组在此基础上给予艾迪注射液治疗。治疗2个月后,观察2组相关症状缓解情况及不良事件发生情况。结果观察组总缓解率高于对照组,不良反应发生率低于对照组,差异均有统计学意义(P<0.05)。结论艾迪注射液联合顺铂与氟尿嘧啶治疗晚期食管癌患者效果显著,可有效控制疾病发展,有利于减轻患者痛苦,且不良事件发生风险较低,值得进一步推广应用。
Objective To observe the effect of Aidi Injection combined with cisplatin and fluorouracil in the treatment of advanced esophageal cancer. Methods 42 patients with advanced esophageal cancer were randomly divided into observation group and control group, 21 cases each. The control group was treated with cisplatin and fluorouracil. The observation group was given Aidi Injection on this basis. After 2 months of treatment, the relief of the related symptoms and the occurrence of adverse events in the two groups were observed. Results The total remission rate of the observation group was higher than that of the control group, and the incidence of adverse reactions was lower than that of the control group (P <0.05). Conclusion Aidi injection combined with cisplatin and fluorouracil in the treatment of advanced esophageal cancer patients with significant effect, which can effectively control the disease, help to reduce the pain of patients, and the risk of adverse events is low, it is worth further promotion and application.